is the fda stopping semaglutide Warns on Certain Forms of Compounded Maximizing Semaglutide: Understanding the Doses

Real-world cohort study: GLP-1 receptor agonist use associated with 3047% reduction in breast cancer risk

Our methods and information are leading the way for the new doctor as the curriculum being taught at licensed educational institutions begins to evolve

B., Fazeli, E., Nreoja, T., Trygg, J., Hnninen, P., Heinze, T., & Fardim, P

The result for over 82% of the population, weight gain after stopping GLP-1

For B12, prolonged use of metformin and acid-suppressing drugs (PPIs, H2 blockers) may reduce absorption of oral B12, which is one reason injectable B12 is considered in select patients

If you are ready to take the next step in your health journey with a team that values personalized care, we invite you to complete the free assessment quiz today